Ordenar

Buscar

01/07/2025 Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation
Griepke, S, Grentzmann, A, Tripodi, GL, Hansen, J, da Fonseca, MP, Nilsson, MD, Tallouzi, Y, Grupe, E, Jensen, PS, Beck, HC, Temprano-Sagrera, G, Sabater-Lleal, M, Burton, M, Dembic, M, Thomassen, M, Forteza, MJ, Terp, MG, Lindholt, JS, Rasmussen, LM, Steffensen, LB, Stubbe, J, Ketelhuth, DFJ. Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation. CARDIOVASCULAR RESEARCH. 2025; 121(8)DOI:10.1093/cvr/cvaf032. PMID:40037693. IF:13.300(Q1/1D).
01/07/2025 Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine"
de Dios, A, Pagès-Puigdemont, N, Ojeda, S, Riera, P, Pelegrin, R, Morollon, N, Belvís, R, Real, J, Masip, M. Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine". HEADACHE. 2025; 65(7)DOI:10.1111/head.14983. PMID:40668957. IF:4.000(Q1/2D).
01/07/2025 A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC
García-González, P, Lara, HR, Compta, Y, Fernandez, M, van der Lee, SJ, de Rojas, I, Saiz, L, Painous, C, Camara, A, Muñoz, E, Marti, MJ, Valldeoriola, F, Puerta, R, Illán-Gala, I, Pagonabarraga, J, Dols-Icardo, O, Kulisevsky, J, Fortea, J, Lleó, A, Olivé, C, de Boer, SCM, Hulsman, M, Pijnenburg, YAL, Belloso, RD, Muñoz-Delgado, L, Rueda, DB, Gómez-Garre, P, Aldecoa, I, Aragonés, G, Vara, JH, Mendioroz, M, Pérez-Tur, J, Visser, PJ, den Braber, A, Papma, JM, Montes, AM, Rodriguez-Rodriguez, E, Blázquez-Folch, J, Miguel, A, García-Gutiérrez, F, Cano, A, Valero, S, Marquié, M, Capdevila-Bayo, M, Rosende-Roca, M, Quintela, I, Carracedo, A, Tàrraga, L, Real, LM, Royo, JL, Erro, ME, Guerrero, C, Torres, DC, Blázquez-Estrada, M, San Millán, B, Teijeira, S, Rolan, DV, Hernández, I, Sánchez-Soblechero, A, de la Casa-Fages, B, López, SS, Baviera-Muñoz, R, Lavín, A, Taipa, R, Amer, G, Martinez-Saez, E, Fernández-Matarrubia, M, Lage-Martínez, C, Alvarez, V, Molina-Porcel, L, Holstege, H, Mir, P, Belbin, O, Boada, M, Fernández, V, Bullido, MJ, Rábano, A, Sánchez-Juan, P, Ruiz, A. A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC. EUROPEAN JOURNAL OF HUMAN GENETICS. 2025; 33(7)DOI:10.1038/s41431-025-01872-3. PMID:40379966. IF:4.600(Q1/2D).
01/07/2025 Development and validation of a risk score to predict community-acquired pneumonia occurrence in the adult population
Prat, MS, Cuevas, AL, Ribas, IB, Fanegas, EP, Pujol, JA. Development and validation of a risk score to predict community-acquired pneumonia occurrence in the adult population. Respiratory Investigation. 2025; 63(4)DOI:10.1016/j.resinv.2025.04.012. PMID:40288222. IF:(Q/D).
01/07/2025 The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma
Agache, I, Salazar, J, Rodriguez-Tanta, Y, Saenz, FKF, Haahtela, T, Traidl-Hoffmann, C, Damialis, A, Vecillas, L, Giovannini, M, Nadeau, KC, Pali-Schöll, I, Palomares, O, Renz, H, Schwarze, J, Pinto, BS, Urrutia-Pereira, M, Venter, C, Vercelli, D, Winders, T, Sola-Arnau, I, Alonso-Coello, P, Canelo-Aybar, C, Jutel, M, Akdis, CA. The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma. ALLERGY. 2025; 80(7)DOI:10.1111/all.16611. PMID:40495394. IF:12.000(Q1/1D).
01/07/2025 Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery
Marcucci, M, Chan, MTV, Painter, TW, Efremov, S, Aguado, HJ, Astrakov, SV, Kleinlugtenbelt, YV, Patel, A, Cata, JP, Amir, M, Kirov, M, Leslie, K, Duceppe, E, Borges, FK, de Nadal, M, Tandon, V, Landoni, G, Likhvantsev, VV, Lomivorotov, V, Sessler, DI, Martínez-Zapata, MJ, Xavier, D, Fleischmann, E, Wang, CY, Meyhoff, CS, Wittmann, M, Torres, D, Highton, D, Jacka, M, Vishwanath, B, Zarnke, K, Sidhu, RS, Oriani, G, Ayad, S, Minear, S, Weaver, TE, Ruetzler, K, Brusasco, C, Parlow, JL, Maxwell, E, Miller, S, Mrkobrada, M, Bhatt, KSC, Rahate, P, Kowark, A, De Blasio, G, Ofori, SN, Conen, D, Srinathan, S, Szczeklik, W, Jayaram, R, Ellerkmann, RK, Momeni, M, Copland, I, Vincent, J, Balasubramanian, K, Li, ZR, Wang, MK, Li, DY, McGillion, MH, Kurz, A, Sharma, M, Short, TG, Devereaux, PJ. Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery. ANNALS OF INTERNAL MEDICINE. 2025; 178(7)DOI:10.7326/ANNALS-24-02841. PMID:40456161. IF:15.200(Q1/1D).
01/07/2025 Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
Ceravalls, J, Giménez-Arnau, AM, Exposito-Serrano, V, Chico, NF, Moya, AL, Bielsa, I, Ribó, P, Mascaró-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Piqué, C, Melé-Ninot, G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2024.08.014. PMID:. IF:(Q/D).
01/07/2025 Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.
Selma-Gonzalez J, Rubio-Guerra S, García-Castro J, Vera-Campuzano E, Sala I, Sánchez-Saudinós MB, Zhu N, Arranz J, Arriola-Infante JE, Rodríguez-Baz Í, Maure-Blesa L, Dols-Icardo O, Videla L, Valldeneu S, Barroeta I, Santos-Santos M, Carmona-Iragui M, Vaqué-Alcázar L, Alvarez-Sanchez E, Lorente O, Carreras M, Belbin O, Arslan B, Ashton NJ, Zetterberg H, Blennow K, Montoliu-Gaya L, Bejanin A, Lleó A, Fortea J, Alcolea D, Illan-Gala I. Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.. NEUROLOGY. 2025; 105(1)DOI:10.1212/WNL.0000000000213769. PMID:40472304. IF:(Q/D).